MedTrace Logo

Observational Study of Vision Improvement in Late Stage Dry AMD Patients

NCT04349254 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2021-02-24

No results posted yet for this study

Summary

The purpose of this study is to assess the vision improvement achieved by patients with late stage dry age-related macular degeneration who received corneal treatments by a low vision aid device.

Conditions

Interventions

DEVICE

Corneal treatment by a low vision aid device

Near infrared light is used to irradiate the cornea to change the modulus of small volumes of anterior stroma. The change of modulus produces a change of corneal stiffness and shape that modifies the distribution of light onto the retina. Light rays are redirected from dysfunctional areas of the retina that have been damaged by age-related macular degeneration (AMD) to functional areas of the retina, thereby improving patient vision.

Sponsors & Collaborators

  • Bochner Eye Institute

    collaborator UNKNOWN

  • Optimal Acuity Corporation

    lead INDUSTRY

Principal Investigators

  • Michael Berry, PhD · Optimal Acuity Corporation

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-14
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04349254 on ClinicalTrials.gov